OBJECTIVE： To provide reference for promoting clinical rational use of Aidi injection. METHODS： Some inpatient records that used Aidi injection in our hospital from Jan. to Jun. 2015 were randomly selected and statistically reviewed by using Excel（2011 edition） in aspects of gender， age， tumor location， usage and dosage， solvents usage， treatment course， adverse reactions， etc. RESULTS： In the 125 patients who used Aidi injection， male was more than female， with average age of 58.4 years； the tumor location of 66 patients （52.80％） was consistent with the indications in instructions； treatment course of 30 patients （24.00％） was consistent with the instructions； all solvent types were consistent with the instruction recommendation， while only 6 patients （4.80％） showed consistence in solvent usage and instructions； 122 patients （97.60％） showed consistence in single dosage and instructions； 7 patients had adverse reactions， mainly rash and gastrointestinal reactions. CONCLUSIONS： The use of Aidi injection in our hospital shows off-label drug use， non-standardized treatment course and inappropriate solvent usage. Physicians， clinical pharmacists and relevant departments should further strengthen the rational use， medical advice comments， supervision and management of Aidi injection in the hospital to promote the rational drug use.